News
News
- Basilea reports positive topline results from phase 2 study FIDES-01 for derazantinib in FGFR2 gene fusion-positive patients with bile duct cancer (iCCA)
02/10/2021 / 07:15 - GlobeNewswire - ClearOne Defeats Shure’s Meritless Preliminary Injunction Motion
02/09/2021 / 15:10 - GlobeNewswire - Amarin Provides Update on VASCEPA® (Icosapent Ethyl) Regulatory Review Processes in Mainland China and Hong Kong
02/09/2021 / 13:00 - GlobeNewswire - STMicroelectronics Announces Status of Common Share Repurchase Program
02/08/2021 / 12:00 - GlobeNewswire - New Kingspan Whitepaper Explores Embodied Carbon Levels in Four Building Envelope Options
02/03/2021 / 15:00 - GlobeNewswire - Guide Dog Foundation Celebrates 75 Years Placing Guide Dogs With Individuals Who Are Blind or Visually Impaired
02/01/2021 / 17:59 - GlobeNewswire - Rapid7 Acquires Leading Kubernetes Security Provider, Alcide
02/01/2021 / 15:05 - GlobeNewswire - National nonprofit shares Black History Month book list for engaging kids in diverse literature year-round
02/01/2021 / 14:05 - GlobeNewswire - VYNE Therapeutics Announces FDA Approval of AMZEEQ® (Minocycline) Label Update
02/01/2021 / 14:00 - GlobeNewswire - Junshi Biosciences and Coherus BioSciences Announce Collaboration to Co-Develop Anti-PD-1 Antibody, Toripalimab, in U.S. and Canada
02/01/2021 / 13:53 - GlobeNewswire
Real-time